McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on ...
McKesson Corporation Reports Strong Q2 Earnings Growth
McKesson Corporation ( (MCK) ) has released its Q2 earnings. Here is a breakdown of the information McKesson Corporation presented to its ...
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now?
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
McKesson's Fiscal Q2 EPS Tops Forecast
McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...
kalkinemedia5h
Baird Sees McKesson Stock Poised for Upside, Driven by US Pharma...
Highlights:,Baird upgraded McKesson Corporation’s stock from Neutral to Outperform, raising its price target to $688 from $531.,McKesson's strong performance in the U.S. Pharmaceutical Distribution ...
Wall Street is mixed as its momentum slows ahead of the Fed's decision
U.S. stocks are mixed on Thursday ahead of the Federal Reserve’s announcement coming in the afternoon about what it will do ...